First Light Asset Management as of June 30, 2015
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 61 positions in its portfolio as reported in the June 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
AtriCure (ATRC) | 9.0 | $19M | 773k | 24.64 | |
NeoGenomics (NEO) | 7.0 | $15M | 2.7M | 5.41 | |
Akorn | 5.8 | $12M | 280k | 43.66 | |
RTI Biologics | 5.2 | $11M | 1.7M | 6.46 | |
Harvard Bioscience (HBIO) | 4.6 | $9.7M | 1.7M | 5.70 | |
AMAG Pharmaceuticals | 3.7 | $7.8M | 113k | 69.06 | |
NxStage Medical | 3.0 | $6.4M | 451k | 14.29 | |
Oxford Immunotec Global | 2.9 | $6.2M | 448k | 13.85 | |
Array BioPharma | 2.9 | $6.1M | 849k | 7.21 | |
Tearlab Corp | 2.9 | $6.1M | 3.0M | 2.02 | |
Spectranetics Corporation | 2.7 | $5.7M | 249k | 23.01 | |
Insmed (INSM) | 2.7 | $5.7M | 232k | 24.42 | |
Omnicell (OMCL) | 2.6 | $5.5M | 147k | 37.71 | |
IGI Laboratories | 2.6 | $5.6M | 881k | 6.30 | |
Veracyte (VCYT) | 2.5 | $5.4M | 482k | 11.14 | |
LHC | 2.4 | $5.0M | 132k | 38.25 | |
Ligand Pharmaceuticals In (LGND) | 2.3 | $5.0M | 49k | 100.91 | |
Celldex Therapeutics | 2.2 | $4.7M | 185k | 25.22 | |
Endologix | 2.2 | $4.7M | 305k | 15.34 | |
Bio-techne Corporation (TECH) | 2.2 | $4.6M | 47k | 98.46 | |
Enzo Biochem (ENZ) | 2.0 | $4.4M | 1.4M | 3.03 | |
Cynapsus Therapeutics | 2.0 | $4.2M | 259k | 16.29 | |
Quidel Corporation | 1.9 | $4.0M | 173k | 22.95 | |
AngioDynamics (ANGO) | 1.8 | $3.9M | 237k | 16.40 | |
LeMaitre Vascular (LMAT) | 1.8 | $3.9M | 321k | 12.06 | |
Alkermes (ALKS) | 1.6 | $3.5M | 55k | 64.35 | |
Cepheid | 1.6 | $3.3M | 55k | 61.14 | |
HealthStream (HSTM) | 1.4 | $3.1M | 101k | 30.42 | |
Streamline Health Solutions (STRM) | 1.4 | $3.0M | 1.1M | 2.80 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.2 | $2.6M | 21k | 123.47 | |
D Fluidigm Corp Del (LAB) | 1.1 | $2.4M | 98k | 24.20 | |
BioMarin Pharmaceutical (BMRN) | 1.1 | $2.2M | 16k | 136.76 | |
Bluebird Bio (BLUE) | 0.9 | $2.0M | 12k | 168.40 | |
Sunopta (STKL) | 0.8 | $1.7M | 162k | 10.73 | |
Verastem | 0.8 | $1.7M | 229k | 7.54 | |
Esperion Therapeutics (ESPR) | 0.8 | $1.6M | 20k | 81.74 | |
Cytokinetics (CYTK) | 0.7 | $1.5M | 219k | 6.72 | |
Aratana Therapeutics | 0.5 | $1.1M | 71k | 15.12 | |
Humana (HUM) | 0.3 | $677k | 3.5k | 191.24 | |
Anthem (ELV) | 0.3 | $672k | 4.1k | 164.10 | |
Aetna | 0.3 | $665k | 5.2k | 127.52 | |
United Therapeutics Corporation (UTHR) | 0.3 | $664k | 3.8k | 173.82 | |
Endo International (ENDPQ) | 0.3 | $650k | 8.2k | 79.65 | |
Mylan Nv | 0.3 | $663k | 9.8k | 67.83 | |
Allergan | 0.3 | $618k | 2.0k | 303.69 | |
Novartis (NVS) | 0.3 | $597k | 6.1k | 98.35 | |
Bristol Myers Squibb (BMY) | 0.3 | $552k | 8.3k | 66.59 | |
Becton, Dickinson and (BDX) | 0.2 | $481k | 3.4k | 141.68 | |
Celgene Corporation | 0.2 | $495k | 4.3k | 115.65 | |
Eli Lilly & Co. (LLY) | 0.2 | $459k | 5.5k | 83.53 | |
St. Jude Medical | 0.2 | $442k | 6.1k | 73.00 | |
Steris Corporation | 0.2 | $408k | 6.3k | 64.45 | |
Johnson & Johnson (JNJ) | 0.2 | $372k | 3.8k | 97.38 | |
Merck & Co (MRK) | 0.2 | $376k | 6.6k | 56.88 | |
Community Health Systems (CYH) | 0.2 | $387k | 6.1k | 62.98 | |
Pfizer (PFE) | 0.2 | $353k | 11k | 33.56 | |
AstraZeneca (AZN) | 0.2 | $362k | 5.7k | 63.73 | |
Amgen (AMGN) | 0.2 | $358k | 2.3k | 153.65 | |
Sanofi-Aventis SA (SNY) | 0.1 | $281k | 5.7k | 49.47 | |
Myriad Genetics (MYGN) | 0.1 | $266k | 7.8k | 34.02 | |
Bio-Rad Laboratories (BIO) | 0.1 | $252k | 1.7k | 150.45 |